Login / Signup

An exploration in pitfalls in interpreting SDHB immunohistochemistry.

Chien-Kuang Cornelia DingSalina ChanJulie MakSarah E UmetsuJeffry P SimkoRoberto Ruiz-CorderoTara SaundersEmily Chan
Published in: Histopathology (2022)
When evaluating SDHB-IHC, care should be taken to distinguish true retained expression from aberrant cytoplasmic expression, which may be difficult to appreciate. Sometimes this may require additional molecular testing.
Keyphrases
  • poor prognosis
  • healthcare
  • binding protein
  • quality improvement
  • long non coding rna
  • pain management
  • single molecule